Alternate Health Closes $4 Million in Financing

Toronto, Ontario--(Newsfile Corp. - February 19, 2020) - Alternate Health Corp., (CSE: AHG) (OTCQB: AHGIF) ("Alternate Health" or the "Company"), an international leader in CBD product development and distribution, announced today that the Company has signed a binding distribution agreement (the "Agreement") with Safe Harvest LLC ("Safe Harvest"), a Texas-based producer of CBD and CBG products, including isolate, distillate and gummies. The Agreement includes a CAD $2.1 Million (USD $1.6 Million) strategic investment in Alternate Health.

"This Agreement represents an important step forward in our CBD business model and a strong show of confidence from a leading industry player," says Howard Mann, CEO of Alternate Health. "Our agreement expands our FDA-compliant testing and packaging division, while adding to our product offering, including high quality CBG, or cannabigerol."

Under the Agreement, Safe Harvest appoints Alternate Health as its exclusive distributor of FDA-compliant, stamped and packaged hemp products. And Alternate Health appoints Safe Harvest as the Company's exclusive provider of CBD and CBG isolate, distillate and gummies.

"We are excited to partner with Safe Harvest and work closely to capture the rapidly developing CBG market," says Howard Mann. "We see excellent potential to build on our complementary capabilities and drive revenues for both businesses."

Agreement Terms

Under the terms of the Agreement, which closed today, Alternate Health will issue 13,333,333 common shares to Safe Harvest, at a deemed price of USD $0.12 (CAD $0.16) per share, in return for a USD $1.6 million (CAD $2.1 million) strategic investment. The investment consists of USD $800,000 (CAD $1,054,000) in cash payments and USD $800,000 (CAD $1,054,000) in prepaid inventory, including CBD and CBG isolate, distillate and gummies. Alternate Health will also issue 833,333 common shares to Safe Harvest, at a deemed price of USD $0.12 (CAD $0.16) per share as consideration for $100,000 in initial inventory, including CBD and CBG isolate and CBD gummies.

Private Placement of Units

Alternate Health also announces that the Company has closed a non-brokered private placement of 13,645,044 units at a price of CAD $0.15 (USD $0.11) per unit for aggregate gross proceeds of CAD $1,981,800. Each unit is comprised of one common share and one share purchase warrant at an exercise price of CAD $0.30 for an 18-month term.

"The Company is pleased to receive a strong show of support from a key insider, demonstrating confidence in Alternate Health's strategic plan," says Howard Mann. "These investments position us for success as the CBD industry continues to mature and transition in the United States."

The common shares and warrants issued under the private placement are subject to a four month and one day hold period in accordance with Canadian securities laws. In addition to funding expansion opportunities in wholesale CBD distribution, the private placement proceeds will be used in expanding Alternate Health's CBD product line and for general working capital purposes.

One of the purchasers in the private placement is a director of the Company. Participation of an insider of the Company in the Private Placement constitutes a related party transaction as defined under Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions. Because the Company's shares trade only on the Canadian Securities Exchange, the issuance of securities is exempt from the formal valuation requirements of Section 5.4 of MI 61-101 pursuant to Subsection 5.5(b) of MI 61-101 and exempt from the minority approval requirements of Section 5.6 of MI 61-101 pursuant to Subsection 5.7(b) of MI 61-101.

About Alternate Health

Alternate Health is an international leader in the hemp-derived CBD industry, including extraction, product development and distribution. Through Alternate Health's subsidiary, Blaine Labs, the Company has 23 years of experience in FDA-registered and cGMP medical product manufacturing and distribution, with over 50 product SKUs available from major retailers, including Walmart, Amazon, CVS and Walgreens. For more information about Alternate Health Corp., visit

Investor Contact

Scott Holtby | Investor Relations

Jim Tykoliz | Company Director


Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. Statements included in this announcement, including statements concerning our plans, intentions and expectations, including with respect to the closing of the letter of intent, which are not historical in nature are intended to be, and are hereby identified as "forward-looking statements". Forward-looking statements may be identified by words including "anticipates", "believes", "intends", "estimates", "expects" and similar expressions. The Company cautions readers that forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements.


To view the source version of this press release, please visit